Impax Laboratories, Inc.

Text (OCR of the scan at left; may contain errors)

IN THE MATTER OF IMPAX LABORATORIES, INC.

Docket No. 9373. Order, August 15, 2018 Order scheduling oral argument in this Matter.

ORDER SCHEDULING ORAL ARGUMENT Complaint Counsel have filed their Appeal Brief perfecting their appeal from the Initial Decision in this matter; the Respondent has filed its Answering Brief; and Complaint Counsel must file their Reply Brief on or before August 24, 2018. Commission Rule 3.52(b)(2) provides that the Commission ordinarily will schedule an Oral Argument within fifteen days after the date on which the Reply Brief is filed. Commission Rule 3.51(a), however, provides that the Commission may extend for good cause any of the time periods relating to an appeal from an Initial Decision, and a new Member of the Commission will take office in the near future. The Commission therefore has determined to conduct the Oral Argument in this matter on October 11, 2018, at 2 p.m. in Hearing Room 532 of the Headquarters Building of the Federal Trade Commission, located at 600 Pennsylvania Avenue, N.W., Washington, D.C. 20580. Each side will be allotted forty-five minutes to present its argument. Complaint Counsel will have the opportunity to open the argument and will be permitted to reserve time for rebuttal. If either side wishes to provide the Commission with a short written or electronic compilation of material to facilitate its presentation during the Oral Argument, any such compilation may contain only public information that is already in the record of the proceeding, and copies must be filed with the Secretary of the Commission and provided to opposing counsel no later than October 4, 2018, at 5 pm.

By the Commission, Commissioner Ohlhausen not participating. 525 IMPAX LABORATORIES, INC.

Interlocutory Orders, Etc.